Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03145181
Title Dose Escalation Study of JNJ-64007957, a Humanized BCMA CD3 DuoBody® Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
Acronym MajesTEC-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | FRA | ESP

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects New York New York 10029 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Centre hospitalier Lyon-Sud Pierre Benite cedex 69495 France Details
CHRU Tours Hopital Bretonneau Tours 37044 France Details
VU Medisch Centrum Amsterdam 1081 HV Netherlands Details
Hosp. Univ. Germans Trias I Pujol Badalona 08916 Spain Details
Hosp Clinic de Barcelona Barcelona 08036 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hosp Clinico Univ de Salamanca Salamanca 37007 Spain Details
Haematology Centre, R 51 Stockholm SE-141 86 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field